Works by Cho, Hyungwoo

Results: 37
    1
    2
    3

    Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404).

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 2, p. 684, doi. 10.4143/crt.2022.1434
    By:
    • Hyungwoo Cho;
    • Dok Hyun Yoon;
    • Dong-Yeop Shin;
    • Youngil Koh;
    • Sung-Soo Yoon;
    • Seok Jin Kim;
    • Young Rok Do;
    • Gyeong-Won Lee;
    • Jae-Yong Kwak;
    • Yong Park;
    • Min Kyoung Kim;
    • Hye Jin Kang;
    • Jun Ho Yi;
    • Kwai Han Yoo;
    • Won Sik Lee;
    • Byeong Bae Park;
    • Jae Cheol Jo;
    • Hyeon-Seok Eom;
    • Hyo Jung Kim;
    • Seong Hyun Jeong
    Publication type:
    Article
    4
    5
    6

    Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 12, p. 1280, doi. 10.1002/ajh.24891
    By:
    • Cho, Hyungwoo;
    • Yoon, Dok Hyun;
    • Lee, Jung Bok;
    • Kim, Sung-Yong;
    • Moon, Joon Ho;
    • Do, Young Rok;
    • Lee, Jae Hoon;
    • Park, Yong;
    • Lee, Ho Sup;
    • Eom, Hyeon Seok;
    • Shin, Ho-Jin;
    • Min, Chang-Ki;
    • Kim, Jin Seok;
    • Jo, Jae-Cheol;
    • Kang, Hye Jin;
    • Mun, Yeung-Chul;
    • Lee, Won Sik;
    • Lee, Je-Jung;
    • Suh, Cheolwon;
    • Kim, Kihyun
    Publication type:
    Article
    7
    8

    Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study.

    Published in:
    Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01886-9
    By:
    • Zhang, Yunlin;
    • Patel, Ruchi P.;
    • Kim, Ki Hyun;
    • Cho, Hyungwoo;
    • Jo, Jae-Cheol;
    • Jeong, Seong Hyun;
    • Oh, Sung Yong;
    • Choi, Yoon Seok;
    • Kim, Sung Hyun;
    • Lee, Ji Hyun;
    • Angelos, Mathew;
    • Guruprasad, Puneeth;
    • Cohen, Ivan;
    • Ugwuanyi, Ositadimma;
    • Lee, Yong Gu;
    • Pajarillo, Raymone;
    • Cho, Jong Hyun;
    • Carturan, Alberto;
    • Paruzzo, Luca;
    • Ghilardi, Guido
    Publication type:
    Article
    9
    10
    11

    Evaluation of the R2-ISS in real-world patients with newly diagnosed multiple myeloma: A nationwide cohort study by the Korean Multiple Myeloma Working Party (KMM 2202).

    Published in:
    HemaSphere, 2024, v. 8, n. 1, p. 1, doi. 10.1002/hem3.33
    By:
    • Hyungwoo Cho;
    • Kihyun Kim;
    • Sang Eun Yoon;
    • Sung-Hoon Jung;
    • Je-Jung Lee;
    • Joon Ho Moon;
    • Hee Jeong Cho;
    • Ho Sup Lee;
    • Ka-Won Kang;
    • Sung-Yong Kim;
    • Hyeon-Seok Eom;
    • Yeung-Chul Mun;
    • Young Hoon Park;
    • Sung-Soo Yoon;
    • Young Rok Do;
    • Won Sik Lee;
    • Chang-Ki Min;
    • Dok Hyun Yoon
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Prognostic implications of hepatitis B virus infection in intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin.

    Published in:
    International Journal of Biological Markers, 2018, v. 33, n. 4, p. 432, doi. 10.1177/1724600818777239
    By:
    • Chae, Heejung;
    • Cho, Hyungwoo;
    • Yoo, Changhoon;
    • Kim, Kyu-pyo;
    • Jeong, Jae Ho;
    • Chang, Heung-Moon;
    • Kang, Jihoon;
    • Lee, Han Chu;
    • Lim, Young-Suk;
    • Kim, Kang Mo;
    • Shim, Ju Hyun;
    • Lee, Sang Soo;
    • Park, Do Hyun;
    • Song, Tae Jun;
    • Hwang, Shin;
    • Song, Gi-Won;
    • Moon, Deok-Bog;
    • Lee, Young-Joo;
    • Lee, Jae Hoon;
    • Ryoo, Baek-Yeol
    Publication type:
    Article
    21
    22
    23
    24
    25

    Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin.

    Published in:
    Investigational New Drugs, 2018, v. 36, n. 3, p. 496, doi. 10.1007/s10637-017-0548-7
    By:
    • Cho, Hyungwoo;
    • Yoo, Changhoon;
    • Kim, Kyu-pyo;
    • Jeong, Jae Ho;
    • Kang, Jihoon;
    • Chang, Heung-Moon;
    • Lee, Sang Soo;
    • Park, Do Hyun;
    • Song, Tae Jun;
    • Lee, Sung Koo;
    • Kim, Myung-Hwan;
    • Lee, Han Chu;
    • Lim, Young-Suk;
    • Kim, Kang Mo;
    • Shim, Ju Hyun;
    • Hwang, Shin;
    • Song, Gi-Won;
    • Moon, Deok-Bog;
    • Lee, Jae Hoon;
    • Lee, Young-Joo
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33

    A prognostic index for extranodal marginal‐zone lymphoma based on the mucosa‐associated lymphoid tissue International Prognostic Index and serum β2‐microglobulin levels.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 2, p. 307, doi. 10.1111/bjh.17222
    By:
    • Kim, Hyung‐Don;
    • Cho, Hyungwoo;
    • Jeong, Hyehyun;
    • Bang, Kyunghye;
    • Kim, Shin;
    • Lee, Kyoungmin;
    • Kang, Eun Hee;
    • Park, Jung Sun;
    • Park, Chan‐Sik;
    • Huh, Jooryung;
    • Ryu, Jin‐Sook;
    • Lee, Sang‐Wook;
    • Yoon, Dok Hyun;
    • Oh, Sung Yong;
    • Suh, Cheolwon
    Publication type:
    Article
    34
    35
    36
    37